California Democratic Governor Gavin Newsom said on Monday his state would cut ties with Walgreens following the drugstore chain’s decision not to sell abortion pills in nearly two dozen states.
“California won’t be doing business with [Walgreens] — or any company that cowers to the extremists and puts women’s lives at risk,” Newsom tweeted. “We’re done.”
A spokesperson for Newsom further noted that “all relationships” between Walgreens and California are under review, according to Reuters.
California won't be doing business with @walgreens — or any company that cowers to the extremists and puts women's lives at risk.
We're done.https://t.co/OB10cYfm8H
— Gavin Newsom (@GavinNewsom) March 6, 2023
A Walgreens representative declined to comment on Newsom’s tweet but did share a general statement with The Daily Wire about Mifepristone, one of two drugs used in medical abortions.
“We want to be very clear about what our position has always been: Walgreens plans to dispense Mifepristone in any jurisdiction where it is legally permissible to do so,” a Walgreens spokesperson said.
“Once we are certified by the [Food and Drug Administration], we will dispense this medication consistent with federal and state laws,” the spokesperson added. “Providing legally approved medications to patients is what pharmacies do, and is rooted in our commitment to the communities in which we operate.”
Walgreens, which operates nearly 9,000 retail locations across the United States, told POLITICO last week it would not distribute abortion pills in almost two dozen states where the attorneys general threatened legal action over the sale of abortion pills by mail in their states.
In four of the states — Alaska, Iowa, Kansas, and Montana — abortion remains legal after the Supreme Court ruling last summer overturning the 1973 Roe v. Wade decision.
CLICK HERE TO GET THE DAILY WIRE APP
However, these largely conservative states have all pushed for more restrictions, and their attorneys general have joined a lawsuit seeking to overturn the Food and Drug Administration’s approval of using Mifepristone for abortions.
The Guttmacher Institute, a research and policy organization focused on sexual and reproductive health, released an analysis last year that found medication abortions accounted for more than half of all facility-based abortions performed in the United States in 2020.
